MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia. Pastoors D, Havermans M, Mulet-Lazaro R, Smeenk L, et al. Blood 2025 Oct 8:blood.2025028914. doi: 10.1182/blood.2025028914.

Read + Share

Amedeo Smart

Independent Medical Education

Pastoors D, Havermans M, Mulet-Lazaro R, Smeenk L, et al. MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia. Blood 2025 Oct 8:blood.2025028914. doi: 10.1182/blood.2025028914.
PMID: 41060369